Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
Launched by STEPHEN NICHOLLS · Apr 5, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The clinical trial titled "Guideline Oriented Approach To Lipid Lowering In Asia-Pacific" is looking at ways to lower cholesterol levels in patients with heart conditions, specifically those who have had a heart attack. The goal is to see if starting treatment right away or waiting six months makes a difference in patient outcomes. This study is being conducted in hospitals across multiple countries, and they are actively recruiting participants.
To be eligible for this trial, patients should be at least 18 years old and have been admitted to the hospital for a specific type of heart attack called Type I myocardial infarction. Some individuals may not qualify if their cholesterol levels are already low or if they cannot provide their doctor’s contact information or give consent to participate. Those who join the study will be randomly assigned to receive the cholesterol-lowering treatment either immediately or after six months, allowing researchers to compare the results of both groups. This trial aims to find out the best approach to help improve heart health in people with high cholesterol in the Asia-Pacific region.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years of age
- • Admission for Type I myocardial infarction
- Exclusion Criteria:
- • LDL \<1.4mmol/L at baseline
- • Unable to provide contact details of primary care physician/general practitioner
- • Unable to provide written informed consent.
- • Unlikely to survive \>12 months
About Stephen Nicholls
Stephen Nicholls is a dedicated clinical trial sponsor with a focus on advancing medical research and improving patient outcomes. With a robust background in cardiovascular health, he leads initiatives that aim to explore innovative therapeutic approaches and enhance clinical practice. Committed to rigorous scientific standards and ethical oversight, Nicholls ensures that all trials are designed and executed with the utmost integrity. His leadership fosters collaboration among multidisciplinary teams, driving the development of groundbreaking treatments that address unmet medical needs. Through a patient-centered approach, Stephen Nicholls is devoted to translating research findings into real-world applications, ultimately contributing to the advancement of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bedford Park, South Australia, Australia
Bangkok, , Thailand
Bangkok, , Thailand
Seoul, , Korea, Republic Of
Songkhla, , Thailand
Fukuoka, , Japan
Mitaka, , Japan
Osaka, , Japan
Singapore, , Singapore
Wollongong, New South Wales, Australia
Osaka, , Japan
Clayton, Victoria, Australia
Pyeongchon, , Korea, Republic Of
Seoul, , Korea, Republic Of
Shah Alam, Selangor, Malaysia
Khon Kaen, , Thailand
Nonthaburi, , Thailand
Cairns, Queensland, Australia
Singapore, , Singapore
Pyeongchon, Gyeonggi Province, Korea, Republic Of
Patients applied
Trial Officials
Stephen Nicholls, MBBS, PhD
Principal Investigator
Monash University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials